A biorelevant dissolution stress test device – background and experiences

Bibliography

• Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930-34
   Google Scholar
• Bruner L, Tolloczko S. On the dissolution speed of firm bodies. Z Physik Ch 1900;35:283-90
   Google Scholar
• Nernst W, Brunner E. Theorie der reaktionsgeschwindigkeit in heterogenen systemen. Z Phys Chem 1904;47:52-5
   Google Scholar
• Banakar UV. (1992) Pharmaceutical dissolution testing. New York; Marcel Dekker Inc.
   Google Scholar
• Siewert M. FIP guidelines for dissolution testing of solid oral products. Drug Info J 1996;30:1071-84
   Google Scholar
• European Pharmacopoeia Edition 6.3. Legally valid from 1.1.2009 until 31.3.2009. Available from: www.pheur.org [Last accessed October 2010]
   Google Scholar
• USP Pharmacopoeia and National Formulary, United States Pharmacopoeial Convention, Inc., 29th edition and 24th edition, 2006
   Google Scholar
• Commission Regulation (EC) No 1084/2003, 2003, EMEA, London
   Google Scholar
• Committee for Proprietary Medicinal Products, (2001). Note for guidance on the investigation of bioavailability and bioequivalence CMP/EWP/QWP1401/98 EMEA, London
   Google Scholar
• Gupta E, Barends DM, Yamashita E, Review of global regulations concerning biowaivers for immediate release solid oral dosage forms. Eur J Pharm Sci 2006;29:315-24
   PubMed Web of Science ®Google Scholar
• Gaynor C, Dunne1 A, Davis J. A comparison of the prediction accuracy of two IVIVC modelling techniques. J Pharm Sci 2008;8:3422-32
   Google Scholar
• Polli JE. Dependence of in vitro-in vivo correlation analysis acceptability on model selections. Pharm Dev Technol 1999;4:89-96
   PubMed Web of Science ®Google Scholar
• McAllister M. Dynamic dissolution: a step closer to predictive dissolution testing. Mol Pharm 2010;7:1374-87
   PubMed Web of Science ®Google Scholar
• Russell TL, Berardi RR, Barnett JL, Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women. Pharm Res 1993;10:187-96
   PubMed Web of Science ®Google Scholar
• Kalantzi L, Goumas K, Kalioras V, Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2006;23:165-76
   PubMed Web of Science ®Google Scholar
• Galia E, Nicolaides E, Horter D, Evaluation of various dissolution media for predicting in vivo performance of Classes I and II drugs. Pharm Res 1998;15:698-705
   PubMed Web of Science ®Google Scholar
• Jantratid E, Janssen N, Reppas C, Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res 2008;25:1663-76
   PubMed Web of Science ®Google Scholar
• Ghazal HS, Dyas AM, Ford JL, In vitro evaluation of the dissolution behaviour of itraconazole in bio-relevant media. Int J Pharm 2009;366:117-23
   PubMed Web of Science ®Google Scholar
• Klein S, Butler J, Hempenstall JM, Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts. J Pharm Pharmacol 2004;56:605-10
   PubMed Web of Science ®Google Scholar
• Kavanagh N, Corrigan OI. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices-influence of agitation rate and dissolution medium composition. Int J Pharm 2004;279:141-52
   PubMed Web of Science ®Google Scholar
• Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001;46:75-87
   PubMed Web of Science ®Google Scholar
• Anwar S, Fell JT, Dickinson PA. An investigation of the disintegration of tablets in biorelevant media. Int J Pharm 2005;290:121-27
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Albery T, Eriksson A, Food effects on tablet disintegration. Eur J Pharm Sci 2004;22:165-72
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Johansson D, Torstensson A, Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine. Pharm Res 1994;11:1093-97
   PubMed Web of Science ®Google Scholar
• Zoeller T, Klein S. Simplified biorelevant media for screening dissolution performance of poorly soluble drugs. Dissol Technol 2007;14:8-13
   Web of Science ®Google Scholar
• Taupitz T, Klein S. Can biorelevant media be simplified by using SLS and tween 80 to replace bile compounds? Open Drug Deliv J 2010;4:30-7
   Google Scholar
• Soni T, Nagda C, Gandhi T, Chotai NP. Development of discriminating method for dissolution of aceclofenac marketed formulations. Dissol Technol 2008;15:31-5
   Web of Science ®Google Scholar
• Bertocchia P, Antoniella E, Valvo L, Diclofenac sodium multisource prolonged release tablets—a comparative study on the dissolution profiles. J Pharm Biomed Anal 2005;37:679-85
   PubMed Web of Science ®Google Scholar
• Kamba M, Seta Y, Kusai A, A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract. Int J Pharm 2000;208:61-70
   PubMed Web of Science ®Google Scholar
• Katori N, Ma WS, Aoyagi N, Effect of destructive force on drug release from multiple unit conlrolled release dosage forms in humans. Pharm Res 1996;13:1541-46
   PubMed Web of Science ®Google Scholar
• Weitschies W, Kosch O, Monnikes H, Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv Drug Deliv Rev 2005;57:1210-22
   PubMed Web of Science ®Google Scholar
• Weitschies W, Blume H, Monnikes H. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract. Eur J Pharm Biopharm 2010;74:93-101
   PubMed Web of Science ®Google Scholar
• Laulicht B, Tripathi A, Schlageter V, Understanding gastric forces calculated from high-resolution pill tracking. PNAS 2010;107:8201-6
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Anupam P, Sjoberg M, A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach. Pharm Res 2005;22:1215-26
   PubMed Web of Science ®Google Scholar
• Schulze K. Imaging and modelling of digestion in the stomach and the duodenum. Neurogastroenterol Motil 2006;18:172-83
   PubMed Web of Science ®Google Scholar
• Pal A, Brasseur J, Abrahamsson B. A stomach road or ‘Magenstrasse’ for gastric emptying. J Biomech 2007;40:1202-10
   PubMed Web of Science ®Google Scholar
• Cassilly D, Kantor S, Knight LC, Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil 2008;20:311-19
   PubMed Web of Science ®Google Scholar
• Dinning PG, Bampton PA, Kennedy ML, Basal pressure patterns and reflexive motor responses in the human ileocolonic junction. Am J Physiol 1999;276:G331-40
   PubMed Web of Science ®Google Scholar
• Schiller C, Frohlich CP, Giessmann T, Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2005;22:971-79
   PubMed Web of Science ®Google Scholar
• Meredith PA. The unique adalat story – nifedipine gastrointestinal therapeutic system. European Cardiovascular Disease 2007;1:97-102
   Google Scholar
• Wikstrand J. Achieving optimal beta1-blockade with metoprolol CR/Zok. Basic Res Cardiol 2000;95:I46-51
   PubMed Web of Science ®Google Scholar
• Breekveldt-Postma NS, Herings RM. Persistence with antihypertensives related to formulation: the case of nifedipine. Ann Pharmacother 2005;39:237-42
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Allpsten M, Bake B. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. J Control Release 1998;52:301-10
   PubMed Web of Science ®Google Scholar
• Wonnemann M, Schug B, Schmucker K. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union. Int J Clin Pharmacol Ther 2006;44:38-48
   PubMed Web of Science ®Google Scholar
• Weitschies W, Wedemeyer RS, Kosch O, Impact of the intragastric location of extended release tablets on food interactions. J Control Release 2005;108:375-85
   PubMed Web of Science ®Google Scholar
• Schug B, Brendel E, Wolf D, Formulation dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union. Eur J Pharm Sci 2002;15:279-85
   PubMed Web of Science ®Google Scholar
• Klein S. Predicting food effects on drug release from extended-release oral dosage forms containing a narrow therapeutic index drug. Dissol Technol 2009;16:28-40
   Web of Science ®Google Scholar
• Jantratid E, De Maio V, Ronda E, Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. Eur J Pharm Sci 2009;37:434-41
   PubMed Web of Science ®Google Scholar
• Garbacz G, Wedemeyer RS, Nagel S, Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Eur J Pharm Biopharm 2008;70:421-8
   PubMed Web of Science ®Google Scholar
• Aoki S, Ando H, Tatsuishi K, Determination of the mechanical impact force in the in vitro dissolution test and evaluation of the correlation between in vivo and in vitro release. Int J Pharm 1993;95:67-75
   Web of Science ®Google Scholar
• Qureshi SA. Improved drug dissolution and product characterization using a crescent-shaped spindle. J Pharm Pharmacol 2004;56:1135-41
   PubMed Web of Science ®Google Scholar
• Qureshi SA. A new crescent-shaped spindle for drug dissolution testing – but why a new spindle? Dissol Technol 2004;11:13-8
   Google Scholar
• Baxter JL, Kukura J, Muzzio FJ. Shear-induced variability in the United States pharmacopeia apparatus 2: modifications to the existing system. AAPS J 2006;7(4):E857-64
   PubMed Web of Science ®Google Scholar
• Parojcic J, Vasiljevic D, Ibric S, Tablet disintegration and drug dissolution in viscous media: paracetamol IR tablets. Int J Pharm 2008;355:93-9
   PubMed Web of Science ®Google Scholar
• Rohrs BR, Burch-Clark DL, Witt MJ, USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations. J Pharm Sci 2006;84:922-26
   Google Scholar
• Kong F, Singh FP. A model stomach system to investigate disintegration kinetics of solid foods during gastric digestion. J Food Sci 2008;73:E202-10
   PubMed Web of Science ®Google Scholar
• Yoo M, Yeon J, Xiao Dong C. GIT physicochemical modeling – a critical review. Int J Food Eng 2006;2: Article 4. Available at: http://www.bepress.com/ijfe/vol2/iss4/art4 DOI: 10.2202/1556-3758
   Web of Science ®Google Scholar
• Blanquet S, Zeijdner E, Beyssac E, A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res 2004;21:585-91
   PubMed Web of Science ®Google Scholar
• Souliman S, Beyssac E, Cardot J-M, Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system. Drug Dev Ind Pharm 2007;33:475-83
   PubMed Web of Science ®Google Scholar
• Souliman S, Blanquet S, Beyssac E, Cardot J-M. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Eur J Pharm Sci 2006;27:72-9
   PubMed Web of Science ®Google Scholar
• Garbacz G, Golke B, Wedemeyer R-S, Comparison of dissolution profiles obtained for nifedipine extended release once daily tablets using different dissolution test apparatuses. Eur J Pharm Sci 2009;38:147-55
   PubMed Web of Science ®Google Scholar
• Garbacz G, Weitschies W. Investigation of dissolution characteristics of four diclofenac sodium extended release tablets using USP apparatus 2 and novel biorelevant dissolution stress test device. Drug Dev Ind Pharm 2010;36:518-30
   Google Scholar
• Garbacz G, Blume H, Weitschies W. Investigation of the dissolution characteristics of six different nifedipine 20 mg extended release tablets using USP apparatus 2 and a novel dissolution test apparatus that mimics in vivo physical stress. Dissol Technologies 2009;16:7-11
   Web of Science ®Google Scholar
• Meredith PA, Elliott HL. Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differences. J Hypertens 2004;22:1641-48
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Santi P, Swellable matrixes for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Tech 2000;6:198-204
   Google Scholar
• Varma MVS, Kaushal AM, Garg A, Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am J Drug Deliv 2004;2:43-57
   Google Scholar
• Colombo P, Bettini R, Peppas NA. Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drug. J Control Release 1999;61:83-91
   PubMed Web of Science ®Google Scholar
• Jamzad S, Tutunji L, Fassihi R. Analysis of macromolecular changes and drug release from hydrophilic matrix systems. Int J Pharm 2005;292:75-85
   PubMed Web of Science ®Google Scholar
• Nazzal S, Nazzal M, El-Malah Y. A novel texture-probe for the simultaneous and real-time measurement of swelling and erosion rates of matrix tablets. Int J Pharm 2007;330:195-98
   PubMedGoogle Scholar
• Yang L, Johnson B, Fassihi R. Determination of continuous changes in the gel layer thickness of poly(ethylene oxide) and HPMC tablets undergoing hydration: a texture analysis study. Pharm Res 1998;12:1902-6
   Google Scholar
• Lia H, Gu X. Correlation between drug dissolution and polymer hydration: a study using texture analysis. Int J Pharm 2007;342:18-25
   PubMedGoogle Scholar
• Pavli M, Kristl J, Dolenc A, The reflection of the texture of swollen polymer matrix on the release of incorporated substance. e-Polymers 2009;17:1-15
   Google Scholar
• Persson E. Drug dissolution under physiologically relevant conditions in vitro and in vivo. Digital comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 39 Acta Universitatis Upsalinesis, Uppsala 2006
   Google Scholar
• Diakidou A, Vertzoni M, Abrahamsson B. Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach. Eur J Pharm Sci 2009;37:133-40
   PubMed Web of Science ®Google Scholar